D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 35,066 216 World Ranking 8835 National Ranking 289

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Disease

His primary areas of study are Rheumatoid arthritis, Internal medicine, Arthritis, Physical therapy and Rheumatology. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Clinical trial, Surgery, Rheumatism, Immunopathology and Severity of illness. His Adalimumab, Autoimmune disease and Erythrocyte sedimentation rate study in the realm of Internal medicine interacts with subjects such as Sulfasalazine.

His Arthritis study combines topics from a wide range of disciplines, such as Prospective cohort study, Pathology, Infliximab and C-reactive protein. His work in the fields of Physical therapy, such as Physical exercise, overlaps with other areas such as In patient. As a member of one scientific family, he mostly works in the field of Rheumatology, focusing on Disease activity and, on occasion, Descriptive statistics.

His most cited work include:

  • Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis (4697 citations)
  • Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria (1311 citations)
  • Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. (868 citations)

What are the main themes of his work throughout his whole career to date?

P.L.C.M. van Riel mainly investigates Rheumatoid arthritis, Internal medicine, Physical therapy, Arthritis and Surgery. His Rheumatoid arthritis research includes elements of Prospective cohort study and Autoimmune disease, Disease. P.L.C.M. van Riel studied Internal medicine and Gastroenterology that intersect with Adalimumab.

His biological study spans a wide range of topics, including Psychological intervention, Epidemiology, Randomized controlled trial, Alternative medicine and Construct validity. He usually deals with Arthritis and limits it to topics linked to Severity of illness and Cohort study. His Surgery research is multidisciplinary, incorporating perspectives in Placebo, Adverse effect and Rheumatoid factor.

He most often published in these fields:

  • Rheumatoid arthritis (67.63%)
  • Internal medicine (60.26%)
  • Physical therapy (27.88%)

What were the highlights of his more recent work (between 2012-2020)?

  • Rheumatoid arthritis (67.63%)
  • Internal medicine (60.26%)
  • Physical therapy (27.88%)

In recent papers he was focusing on the following fields of study:

P.L.C.M. van Riel focuses on Rheumatoid arthritis, Internal medicine, Physical therapy, In patient and Disease. P.L.C.M. van Riel interconnects Psoriasis, Cohort study, Arthritis, Randomized controlled trial and Cohort in the investigation of issues within Rheumatoid arthritis. His research in Arthritis intersects with topics in Prospective cohort study, Scleroderma, Pathology and Wrist.

His studies link Surgery with Internal medicine. P.L.C.M. van Riel combines subjects such as Outpatient clinic, Psychosocial, Cross-sectional study, Cognition and Severity of illness with his study of Physical therapy. His studies in Disease integrate themes in fields like Single-nucleotide polymorphism, Blood pressure and Dutch Population.

Between 2012 and 2020, his most popular works were:

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis (246 citations)
  • Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis (174 citations)
  • The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength. (86 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Disease

His primary areas of investigation include Rheumatoid arthritis, Physical therapy, Internal medicine, In patient and Arthritis. The concepts of his Rheumatoid arthritis study are interwoven with issues in Disease activity, Cohort study, Randomized controlled trial, Cohort and Risk factor. His work deals with themes such as Cross-sectional study, Receiver operating characteristic, Severity of illness and Confidence interval, which intersect with Physical therapy.

His Internal medicine study focuses mostly on Discontinuation, Clinical trial, Case-control study, Rheumatology and Exacerbation. His research integrates issues of Range of motion, Observational study and Predictive value of tests in his study of Clinical trial. He has researched Arthritis in several fields, including Psoriasis, Prospective cohort study, Pathology and Lupus erythematosus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

M.L.L. Prevoo;M.A. van 't Hof;H.H. Kuper;M.A. van Leeuwen.
Arthritis & Rheumatism (1995)

6366 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados.
Revmatologiia (2011)

3007 Citations

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria

A.M. van Gestel;M.L.L. Prevoo;M.A. van 't Hof;M.H. van Rijswijk.
Arthritis & Rheumatism (1996)

2096 Citations

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

D M van der Heijde;M A van 't Hof;P L van Riel;L A Theunisse.
Annals of the Rheumatic Diseases (1990)

1251 Citations

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

J.S. Smolen;F.C. Breedveld;M.H. Schiff;J.R. Kalden.
Rheumatology (2003)

1075 Citations

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

E.J.A. Kroot;B.A.W. de Jong;M.A. van Leeuwen;H.L. Swinkels.
Arthritis & Rheumatism (2000)

1053 Citations

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

A.M. van Gestel;C.J. Haagsma;P.L.C.M. van Riel.
Arthritis & Rheumatism (1998)

876 Citations

The Disease Activity Score and the EULAR response criteria.

J. Fransen;P.L.C.M. van Riel.
Clinical and Experimental Rheumatology (2005)

760 Citations

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

L B A van de Putte;C Atkins;M Malaise;J Sany.
Annals of the Rheumatic Diseases (2004)

735 Citations

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

G. Wells;J.C. Becker;J. Teng;M. Dougados.
Annals of the Rheumatic Diseases (2009)

691 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing P.L.C.M. van Riel

Paul Emery

Paul Emery

University of Leeds

Publications: 256

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 188

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 187

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 156

George D. Kitas

George D. Kitas

Dudley Group NHS Foundation Trust

Publications: 150

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 148

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 145

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 125

Paul P. Tak

Paul P. Tak

GlaxoSmithKline (United Kingdom)

Publications: 120

Deborah P. M. Symmons

Deborah P. M. Symmons

University of Manchester

Publications: 117

Maarten Boers

Maarten Boers

Vrije Universiteit Amsterdam

Publications: 113

Theodore Pincus

Theodore Pincus

Rush University Medical Center

Publications: 109

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 102

Daniel E. Furst

Daniel E. Furst

University of California, Los Angeles

Publications: 102

Michael E. Weinblatt

Michael E. Weinblatt

Brigham and Women's Hospital

Publications: 101

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 101

Trending Scientists

Jianke Zhu

Jianke Zhu

Zhejiang University

Joshua T. Goodman

Joshua T. Goodman

Microsoft (United States)

Ufuk Topcu

Ufuk Topcu

The University of Texas at Austin

Nikolaus P. Ernsting

Nikolaus P. Ernsting

Humboldt-Universität zu Berlin

Peter I. Macreadie

Peter I. Macreadie

Deakin University

Nathan J. B. Kraft

Nathan J. B. Kraft

University of California, Los Angeles

Alicia Teresa Rosario Acosta

Alicia Teresa Rosario Acosta

Roma Tre University

Raymond L. Rodriguez

Raymond L. Rodriguez

University of California, Davis

Fred A. Rainey

Fred A. Rainey

Louisiana State University

Michael Riedel

Michael Riedel

GEOMAR Helmholtz Centre for Ocean Research Kiel

Amaelle Landais

Amaelle Landais

University of Paris-Saclay

Arthur Kaser

Arthur Kaser

University of Cambridge

Laurence Tiret

Laurence Tiret

Sorbonne University

Joseph S. Renzulli

Joseph S. Renzulli

University of Connecticut

Chris Cunneen

Chris Cunneen

University of Technology Sydney

Something went wrong. Please try again later.